cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Vigil Neuroscience Inc
1 own
2 watching
Current Price
$12.09
$0.84
(7.47%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
430.02M
52-Week High
52-Week High
18.27
52-Week Low
52-Week Low
2.18
Average Volume
Average Volume
0.03M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization430.02M
icon52-Week High18.27
icon52-Week Low2.18
iconAverage Volume0.03M
iconDividend Yield--
iconP/E Ratio--
What does the Vigil Neuroscience Inc do?
Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed on myeloid cells 2 (TREM2) which is in Phase I for the treatment of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia, as well as for the treatment of cerebral adrenoleukodystrophy and alzheimer s disease. The company also develops a small molecule TREM2 agonist suitable for oral delivery to treat common neurodegenerative diseases associated with microglial dysfunction. Vigil Neuroscience, Inc. was incorporated in 2020 and is headquartered in Cambridge, Massachusetts.
Read More
How much money does Vigil Neuroscience Inc make?
News & Events about Vigil Neuroscience Inc.
Globe Newswire
2 months ago
CAMBRIDGE, Mass., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc.(Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases, today announced that the Company will host an adult-onset ...
Zolmax
2 months ago
Vigil Neuroscience (NASDAQ:VIGL Get Rating) had its price target hoisted by Morgan Stanley from $11.00 to $12.00 in a report published on Monday morning, MarketBeat reports. The firm currently has an equal weight rating on the stock. Other equities analysts have also issued reports about the stock. ...
Ticker Report
2 months ago
Vigil Neuroscience (NASDAQ:VIGL Get Rating) had its price target hoisted by Morgan Stanley from $11.00 to $12.00 in a report published on Monday morning, MarketBeat reports. The firm currently has an equal weight rating on the stock. Other equities analysts have also issued reports about the...
Globe Newswire
6 months ago
CAMBRIDGE, Mass., Aug. 12, 2022 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc.(Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases, today announced that it has entered into a securities purchase agreement ...
Globe Newswire
10 months ago
- Completed successful initial public offering, raising $98 million in gross proceeds - - Initiated VGL101 Phase 1 trial; Phase 2 trial in ALSP patients expected to initiate in 2H 2022 - - Initiated IND-enabling studies in the small molecule Alzheimers disease TREM2 agonist program - - Advanced ...
Frequently Asked Questions
Frequently Asked Questions
What is Vigil Neuroscience Inc share price today?
plus_minus_icon
Can Indians buy Vigil Neuroscience Inc shares?
plus_minus_icon
How can I buy Vigil Neuroscience Inc shares from India?
plus_minus_icon
Can Fractional shares of Vigil Neuroscience Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Vigil Neuroscience Inc stocks?
plus_minus_icon
What is today’s traded volume of Vigil Neuroscience Inc?
plus_minus_icon
What is today’s market capitalisation of Vigil Neuroscience Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Vigil Neuroscience Inc?
plus_minus_icon
What percentage is Vigil Neuroscience Inc down from its 52-Week High?
plus_minus_icon
What percentage is Vigil Neuroscience Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$12.09
$0.84
(7.47%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00